Diabetic Retinopathy: Does 12 Weeks of Intensive Lifestyle Intervention Cause Any Improvement?
Journal of The Association of Physicians of India · 2026-03 · 74 (3) · 90-92
DOI: 10.59556/japi.74.1437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of The Association of Physicians of India, 2026-03. Verfasst von Priyal Meghsham Talmale und 2 weiteren Autor:innen. Beteiligte Einrichtung: Junior Resident, Department of Physiology, All India Institute of Medical Sciences, Nagpur, Maharashtra, India, Corresponding Author. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus, Type 2, Life Style. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Junior Resident, Department of Physiology, All India Institute of Medical Sciences, Nagpur, Maharashtra, India, Corresponding Author.
- Professor and Head, Department of Physiology, All India Institute of Medical Sciences, Nagpur, Maharashtra, India, Orcid: https://orcid.org/0009-0006-2092-2610.
- Additional Professor Department of Ophthalmology, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
Zitieren
APA
Talmale, P. M., Phatak, M., & Bang, P. (2026). Diabetic Retinopathy: Does 12 Weeks of Intensive Lifestyle Intervention Cause Any Improvement?. Journal of The Association of Physicians of India, 74(3), 90-92. https://doi.org/10.59556/japi.74.1437
Vancouver
Talmale PM, Phatak M, Bang P. Diabetic Retinopathy: Does 12 Weeks of Intensive Lifestyle Intervention Cause Any Improvement?. Journal of The Association of Physicians of India. 2026;74(3):90-92. doi:10.59556/japi.74.1437
BibTeX
@article{Talmale2026,
author = {Talmale, Priyal Meghsham and Phatak, Mrunal and Bang, Puja},
title = {Diabetic Retinopathy: Does 12 Weeks of Intensive Lifestyle Intervention Cause Any Improvement?},
journal = {Journal of The Association of Physicians of India},
year = {2026},
volume = {74},
number = {3},
pages = {90--92},
doi = {10.59556/japi.74.1437}
}
EUVIMED